These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1692767)
1. Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression. von Knebel Doeberitz M; Gissmann L; zur Hausen H Cancer Res; 1990 Jun; 50(12):3730-6. PubMed ID: 1692767 [TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
3. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860 [TBL] [Abstract][Full Text] [Related]
5. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029 [TBL] [Abstract][Full Text] [Related]
6. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855 [TBL] [Abstract][Full Text] [Related]
7. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150 [TBL] [Abstract][Full Text] [Related]
8. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. von Knebel Doeberitz M; Oltersdorf T; Schwarz E; Gissmann L Cancer Res; 1988 Jul; 48(13):3780-6. PubMed ID: 2837324 [TBL] [Abstract][Full Text] [Related]
9. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange. Subbaramaiah K; Dannenberg AJ Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114 [TBL] [Abstract][Full Text] [Related]
11. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269 [TBL] [Abstract][Full Text] [Related]
12. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA. Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012 [TBL] [Abstract][Full Text] [Related]
13. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347 [TBL] [Abstract][Full Text] [Related]
14. Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone. Yuan F; Auborn K; James C Cancer Invest; 1999; 17(1):19-29. PubMed ID: 10999045 [TBL] [Abstract][Full Text] [Related]
16. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017 [TBL] [Abstract][Full Text] [Related]
17. Expression of S100P gene in cervical carcinoma cells is independent of E7 human papillomavirus oncogene. Jakubícková L; Baráthová M; Pastoreková S; Pastorek J; Gibadulinová A Acta Virol; 2005; 49(2):133-7. PubMed ID: 16047742 [TBL] [Abstract][Full Text] [Related]
18. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus]. Velazquez Torres A; Gariglio Vidal P Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893 [TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression. Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909 [TBL] [Abstract][Full Text] [Related]
20. Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells. Reiss M; Stash EB; Vellucci VF; Zhou ZL Cancer Res; 1991 Dec; 51(23 Pt 1):6254-62. PubMed ID: 1933886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]